PD79 Cost Heterogeneity Across Health Sectors And Its Impact On Coverage Decisions for Metastatic Prostate Cancer Treatment In Argentina
Jorge Elgart, Mariana Glancszpigel, Gonzalo Guiñazú, Juan De Bonis, Silvana De Cicco, Lucila Rey-Ares · 2025
Read PD79 Cost Heterogeneity Across Health Sectors And Its Impact On Coverage Decisions for Metastatic Prostate Cancer Treatment In Argentina by Jorge Elgart, Mariana Glancszpigel, Gonzalo Guiñazú, Juan De Bonis, Silvana De Cicco, Lucila Rey-Ares (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12768808.txt.
Description
Jorge Elgart and co-authors ask how uneven costs across Argentina's health sectors sway coverage choices, in a 2025 study. The country splits care among public, private, and union-run systems, each paying different prices.
The team used one drug, a treatment for prostate cancer that has spread, as a test case. Holding other factors fixed, they found the cost of basic care items varied by seventy-nine percent across sectors. Doctor visits varied the most, by over three hundred percent, while lab tests varied least. As a result, the yearly budget impact of the drug shifted by over fifteen percent between sectors. The authors urge sector-specific rules for fair coverage calls.
Catalog record
| CREATOR | Jorge Elgart, Mariana Glancszpigel, Gonzalo Guiñazú, Juan De Bonis, Silvana De Cicco, Lucila Rey-Ares |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |